The mutual exclusivity of IDH1 and EGFR mutations suggests divergent oncogenic pathways, with IDH1 mutations predominantly associated with LGGs and EGFR mutations linked to more aggressive glioblastomas [38]. The gene discussed is EGFR; the disease is glioblastoma.